Recap: CASI Pharmaceuticals Q2 Earnings



CASI Pharmaceuticals CASI reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


CASI Pharmaceuticals beat estimated earnings by 12.5%, reporting an EPS of $-0.56 versus an estimate of $-0.64.

Revenue was up $1.41 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.3 which was followed by a 11.66% increase in the share price the next day.

Here's a look at CASI Pharmaceuticals's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.9 -0.6 -0.5 -0.7
EPS Actual -0.6 -0.4 -0.7 -0.5
Revenue Estimate 9.23M 9.07M 7.54M 6.02M
Revenue Actual 9.06M 9.16M 8.11M 7.16M

To track all earnings releases for CASI Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps